Mercer Global Advisors
AVNS icon

Mercer Global Advisors’s Avanos Medical AVNS Stock Holding History

Mercer Global Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$258K Buy
18,405
+3,041
+20% +$41K ﹤0.01% 2585
2025
Q4 		$173K Sell
15,364
-2,875
-16% -$32.9K ﹤0.01% 2609
2025
Q3 		$211K Buy
+18,239
New +$214K ﹤0.01% 2358

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Mercer Global Advisors's AVNS Position: Q1 2026 in Review

Mercer Global Advisors increased its Avanos Medical (AVNS) stake by 20% in Q1 2026, buying an estimated $41K and bringing the position to 18,405 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #2585.

Mercer Global Advisors first reported a position in AVNS in Q3 2025 and has held it in 3 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Mercer Global Advisors held 18,405 shares of Avanos Medical worth $258K as of Q1 2026.
  • Mercer Global Advisors bought 3,041 Avanos Medical shares in Q1 2026, an estimated $41K.
  • Avanos Medical made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #2585 holding.
  • Mercer Global Advisors first reported a position in Avanos Medical in Q3 2025 and has held it in 3 quarters since.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.